Intersect ENT, Inc. (XENT)
|52 Week Range||15.92-28.25|
|1y Target Est||-|
|DCF Unlevered||XENT DCF ->|
|DCF Levered||XENT LDCF ->|
|Debt / Equity||-235.48%||Sell|
Upgrades & Downgrades
Latest XENT news
Intersect ENT (XENT) Q1 Earnings & Revenues Miss Estimates
10 May 2022
Intersect ENT (XENT) records lower-than-expected revenues for the first quarter, with mounting operating costs impacting the bottom line.
Why Is Intersect ENT (XENT) Down 0.6% Since Last Earnings Report?
2 December 2021
Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock?
Intersect ENT's (XENT) Sell-Off on Track Amid COVID Woes
18 November 2021
Amid industry-wide concerns of deferral of elective procedures, Intersect ENT's (XENT) plans to consolidate with an industry behemoth like Medtronic seems a strategically aligned survival plan.
MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on
30 September 2021
MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intersect ENT, Inc. - XE...
13 September 2021
NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Act...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.
9 August 2021
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Intersect ENT, Inc. (NASDAQ: XENT) and its board of directors concerning the proposed acq...
Intersect ENT (XENT) Q2 Loss Wider Than Expected, Revenues Top
9 August 2021
Intersect ENT's (XENT) second-quarter revenues improved year over year on increased PROPEL and SINUVA sales.
Why Medtronic (MDT) Is Buying Intersect ENT For $1.1 Billion
7 August 2021
Medtronic plc (NYSE:MDT) announced it entered into a definitive agreement with Intersect ENT (NASDAQ: XENT) for $1.1 billion. The post Why Medtronic (MDT) Is Buying Intersect ENT For $1.1 Billion app...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Intersect ENT, Inc.
6 August 2021
NEW YORK, Aug. 6, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intersect ENT, Inc. ("Intersect" or th...